Nivolumab plus ipilimumab for hepatocellular carcinoma: a game-changer?
{{output}}
Introduction: Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide, largely arising in the setting of chronic liver disease and cirrhosis. Given the immunosuppressive hepatic tumor microenv... ...